ResMed | RMD - 税前利润



金融业
股票价格
USD
资产
USD 8.97B
现金及等价物
USD 1.47B
销售成本
USD 612.93M
流动资产
USD 4.32B
流动负债
USD 1.4B
债务
USD 843.17M
股息收益率
0.28
EBIT
USD 454.34M
EBITDA
USD 559.78M
员工
10.6K
EPS每股收益
USD 2.95
股本和储备
USD 6.59B
销售毛利
USD 861.22M
债务利息支出
USD 8.79M
利息收入
USD 59K
贷款资金
USD 399.42M
市值
USD 33.2B
净收入
USD 383.43M
营业费用
USD 1.01B
营业利润
USD 454.34M
普通股股本
USD 145.06M
PE价格收益
18.29
税前利润
USD 502.31M
销售收入
USD 1.46B
销售和管理费用
USD 290.66M
股票
USD 945.81M
贸易债权人
USD 308.92M
应收帐款人
USD 1.04B


税前利润 更改 日
Ansell USD 126.7M 93.35M 2025-12
Artivion USD 11.4M 7.84M 2025-12
AtriCure USD 394K 1.97M 2026-03
Baxter International USD 362M 368M 2026-06
Cochlear AUD 121.1M 155.6M 2025-06
Cooper Companies USD 192.2M 75.4M 2025-12
CSL USD 2.61B 1.21B 2025-12
Dexcom USD 269.5M 71.2M 2026-03
Edwards Lifesciences USD 529.3M 90.4M 2026-06
Fisher Paykel Healthcare NZD 347.7M 50.8M 2026-06
Globus Medical USD 157.07M 12.16M 2026-03
Haemonetics USD 47.57M 75.97M 2026-06
Idexx Laboratories USD 417.22M 61.78M 2026-06
Inogen USD -6.06M 467K 2024-09
Insulet USD 118.7M 5.7M 2026-06
Integra LifeSciences USD -2.41M 6.72M 2026-03
Intuitive Surgical USD 940.4M 15.2M 2026-03
Medtronic USD 2.45B 1.04B 2026-03
Philips EUR 546M 356M 2026-06
Ramsay Health Care AUD 240.5M 136.75M 2025-12
ResMed USD 502.31M 6.16M 2026-03
Sigma Healthcare AUD 8.15M 7.4M 2024-07
Sonic Healthcare AUD 402.01M 53.16M 2025-06
Steris USD 304.5M 46.7M 2026-03
Teleflex USD -3.83M 222.77M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03